Literature DB >> 27307462

Low Utility of Pediatric Isolator Blood Culture System for Detection of Fungemia in Children: a 10-Year Review.

Aaron Campigotto1, Susan E Richardson2, Michael Sebert3, Erin McElvania TeKippe4, Aparna Chakravarty5, Christopher D Doern6.   

Abstract

The use of the Wampole Isolator 1.5-ml pediatric blood culture tube for the detection of fungemia in children was assessed by a 10-year retrospective review at two pediatric hospitals, The Hospital for Sick Children in Toronto, Canada, and the Children's Medical Center of Dallas, Texas. Over this period, a total of 9,442 pediatric Isolator specimens were processed, with yeast or yeast-like organisms recovered in 297 (3.1%) of the specimens (151 [1.6%] unique clinical episodes) and filamentous or dimorphic fungi recovered in 31 (0.3%) of the specimens (25 unique clinical episodes). Only 18 of the 151 clinical episodes of fungemia attributable to yeast were not detected by automated blood culture systems. The majority of isolated yeast were Candida spp., which were usually detected by automated systems, whereas the most common non-Candida yeast was Malassezia furfur, which the automated system failed to detect. Filamentous or dimorphic fungi were detected in 25 episodes, of which only 9 (36%) episodes were deemed clinically significant after chart review, indicating that in the majority of cases (16/25, 64%) fungal isolation represented contamination. In five of the nine clinically significant episodes, the isolated fungus (Histoplasma capsulatum, Coccidioides immitis/posadasii, Fusarium oxysporum, Aspergillus spp., and Bipolaris spp.) was also identified in other clinical specimens. Over the 10-year study period, the use of the pediatric Isolator system, at the discretion of the treating physician, only rarely provided useful clinical information for the diagnosis of fungemia in children, with the exception of M. furfur and possibly endemic mycoses.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27307462      PMCID: PMC5005482          DOI: 10.1128/JCM.00578-16

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

Review 1.  Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies.

Authors:  M E Falagas; K E Apostolou; V D Pappas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-07       Impact factor: 3.267

2.  Controlled clinical laboratory comparison of BACTEC plus aerobic/F resin medium with BacT/Alert aerobic FAN medium for detection of bacteremia and fungemia.

Authors:  J H Jorgensen; S Mirrett; L C McDonald; P R Murray; M P Weinstein; J Fune; C W Trippy; M Masterson; L B Reller
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

3.  Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer.

Authors:  Maria N Chitasombat; Diamantis P Kofteridis; Ying Jiang; Jeffrey Tarrand; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  J Infect       Date:  2011-11-11       Impact factor: 6.072

4.  Lack of utility of the lysis-centrifugation blood culture method for detection of fungemia in immunocompromised cancer patients.

Authors:  R J Creger; K E Weeman; M R Jacobs; A Morrissey; P Parker; R M Fox; H M Lazarus
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

5.  Performance of fungal blood cultures by using the Isolator collection system: is it cost-effective?

Authors:  R M Morrell; B L Wasilauskas; C H Steffee
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

Review 6.  Candidemia in a pediatric population.

Authors:  J K Stamos; A H Rowley
Journal:  Clin Infect Dis       Date:  1995-03       Impact factor: 9.079

7.  Candida albicans and non-albicans bloodstream infections in adult and pediatric patients: comparison of mortality and costs.

Authors:  Cassandra Moran; Chelsea A Grussemeyer; James R Spalding; Daniel K Benjamin; Shelby D Reed
Journal:  Pediatr Infect Dis J       Date:  2009-05       Impact factor: 2.129

8.  Direct comparison of the BACTEC 9240 and BacT/ALERT 3D automated blood culture systems for candida growth detection.

Authors:  Lynn L Horvath; Benjamin J George; Clinton K Murray; Linda S Harrison; Duane R Hospenthal
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

9.  Comparison of the lysis-centrifugation and agitated biphasic blood culture systems for detection of fungemia.

Authors:  P R Murray
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

10.  Clinical significance of non-Candida fungal blood isolation in patients undergoing high-risk allogeneic hematopoietic stem cell transplantation (1993-2001).

Authors:  Amar Safdar; Seema Singhal; Jayesh Mehta
Journal:  Cancer       Date:  2004-06-01       Impact factor: 6.860

View more
  6 in total

1.  Comprehensive Study Identifies a Sensitive, Low-Risk, Closed-System Model for Detection of Fungal Contaminants in Cell and Gene Therapy Products.

Authors:  Nicole E Putnam; Anna F Lau
Journal:  J Clin Microbiol       Date:  2021-08-18       Impact factor: 5.948

Review 2.  Fungal infections in children with haematologic malignancies and stem cell transplant recipients.

Authors:  William R Otto; Abby M Green
Journal:  Br J Haematol       Date:  2020-03-11       Impact factor: 6.998

3.  Recognition of Diagnostic Gaps for Laboratory Diagnosis of Fungal Diseases: Expert Opinion from the Fungal Diagnostics Laboratories Consortium (FDLC).

Authors:  Sean X Zhang; N Esther Babady; Kimberly E Hanson; Amanda T Harrington; Paige M K Larkin; Sixto M Leal; Paul M Luethy; Isabella W Martin; Preeti Pancholi; Gary W Procop; Stefan Riedel; Seyedmojtaba Seyedmousavi; Kaede V Sullivan; Thomas J Walsh; Shawn R Lockhart
Journal:  J Clin Microbiol       Date:  2021-06-18       Impact factor: 5.948

Review 4.  Malassezia: Zoonotic Implications, Parallels and Differences in Colonization and Disease in Humans and Animals.

Authors:  Stefan Hobi; Claudia Cafarchia; Valentina Romano; Vanessa R Barrs
Journal:  J Fungi (Basel)       Date:  2022-07-04

Review 5.  Malassezia spp. Yeasts of Emerging Concern in Fungemia.

Authors:  Wafa Rhimi; Bart Theelen; Teun Boekhout; Domenico Otranto; Claudia Cafarchia
Journal:  Front Cell Infect Microbiol       Date:  2020-07-28       Impact factor: 5.293

Review 6.  Modern Blood Culture: Management Decisions and Method Options.

Authors:  Mark D Gonzalez; Timothy Chao; Matthew A Pettengill
Journal:  Clin Lab Med       Date:  2020-09-19       Impact factor: 1.935

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.